2 results match your criteria: "University Hospitals Gasthuisberg - KU Leuven[Affiliation]"
Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer.
Future Oncol
November 2024
The Department of Medical Oncology, Vall d'Hebron Hospital Campus & Institute of Oncology, International Oncology Bureau-Quiron, Barcelona, Spain.
What Is This Summary About?: This is a summary describing the results from a phase 3 clinical trial called SUNLIGHT. The study looked at treatment with orally administered trifluridine/tipiracil plus intravenously administered bevacizumab in people with metastatic colorectal cancer (mCRC) that is refractory to treatment.This study included people whose cancer had grown or spread beyond its original location after no more than two previous treatments.
View Article and Find Full Text PDFTermination of pregnancy for renal malformations.
Pediatr Nephrol
September 2015
Department of Obstetrics and Gynaecology, University Hospitals Gasthuisberg - KU Leuven, Herestraat 49, 3000, Leuven, Belgium,
Background: We studied the correlation between prenatal diagnosis and postmortem investigations in pregnancies terminated for renal malformations.
Methods: Over a 5-year period, 77 cases of termination of pregnancy (TOP) for renal malformations were reviewed. Chromosomal anomalies (n = 9) and cases without conventional or virtual autopsy were excluded (n = 15).